Antiproliferative and proapoptotic activities of methanolic extracts from ligustrum vulgare L. as an individual treatment and in combination with palladium complex

International Journal of Molecular Sciences

Volumn 13, Issue 2, 2012, Pages 2521-2534

  Ćurčić, Milena G ^a   Stanković, Milan S ^a   Mrkalić, Emina M ^a   Matović, Zoran D ^a   Banković, Dragić D ^a   Cvetković, Danijela M ^a   Dačić, Dragana S ^a   Marković, Snežana D ^a  

^a UNIVERSITY OF KRAGUJEVAC   (Serbia)

Author keywords

Acridin orange ethidium bromide assay; Antiprolifertative activity; Apoptosis; Cotreatment; Ligustrum vulgare L; MTT assay; Palladium; Time dependance

Indexed keywords

ANTINEOPLASTIC AGENT; LIGUSTRUM VULGARE EXTRACT; N,N' BIS(3 AMINOPROPYL)OXAMIDO PALLADIUM COMPLEX; PALLADIUM COMPLEX; PLANT EXTRACT; UNCLASSIFIED DRUG; ANTINEOPLASTIC AGENTS, PHYTOGENIC; METHANOL; PALLADIUM; PLANT EXTRACTS;

ANTIPROLIFERATIVE ACTIVITY; APOPTOSIS; ARTICLE; CANCER CELL CULTURE; CANCER COMBINATION CHEMOTHERAPY; CANCER INHIBITION; CELL DEATH; CELL STRUCTURE; CELL VIABILITY; COLON CANCER; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG CYTOTOXICITY; DRUG EFFECT; DRUG MECHANISM; DRUG POTENTIATION; FLUORESCENCE MICROSCOPY; HUMAN; HUMAN CELL; IC 50; IN VITRO STUDY; LIGUSTRUM; LIGUSTRUM VULGARE; MONOTHERAPY; PLANT LEAF; CELL PROLIFERATION; CHEMISTRY; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG EFFECTS; HCT116 CELLS; HUMANS; PLANT LEAVES; TIME FACTORS;

LIGUSTRUM VULGARE;

ANTINEOPLASTIC AGENTS, PHYTOGENIC; APOPTOSIS; CELL PROLIFERATION; DOSE-RESPONSE RELATIONSHIP, DRUG; HCT116 CELLS; HUMANS; LIGUSTRUM; METHANOL; PALLADIUM; PLANT EXTRACTS; PLANT LEAVES; TIME FACTORS;

EID: 84857662425     PISSN: None     EISSN: 14220067     Source Type: Journal    
DOI: 10.3390/ijms13022521     Document Type: Article

References (33)

1. Jovanović, B. Ligustrum. In Flora of Republic of Serbia, 5th ed.; Josifović, M., Ed.; Serbian Academy of Science and Arts: Belgrade, Serbia, 1973; pp. 456-457.
2. Pieroni, A.; Pachaly, P.; Huang, Y.; van Poel, B.; Vlietinck, A.J. Studies on anti-complementary activity of extracts and isolated flavones from Ligustrum vulgare and Phillyrea latifolia leaves (Oleaceae). J. Ethnopharmacol. 2000, 70, 213-217.
3. Baróniková, S.; Nagy, M.; Grančai, D. Changes in immunomodulatory activity of human mononuclear cells after cultivation with leaf decoctions from the genus Ligustrum L. Phytother. Res. 1999, 13, 692-695.
4. Yim, T.K.; Wu, W.K.; Pak, W.F.; Ko, K.M. Hepatoprotective action in an oleanolic acid-enriched extracts of Ligustrum lucidum fruits is mediated through an enhancement on hepatic glutathione regeneration capacity in mice. Phytother. Res. 2001, 15, 589-592.
5. Jantová, S.; Nagy, M.; Ružeková, L.; Grančai, D. Antibacterial activity of plant extracts from the families Fabaceae, Oleaceae, Philadelphaceae, Rosaceae and Staphyleaceae. Phytother. Res. 2000, 14, 601-603.
6. Andrade-Cetto, A.; Henrich, M. Mexican plants with hypoglycaemic effect used in the treatment of diabetes. J. Ethnopharmacol. 2005, 99, 325-348.
7. Sersen, F.; Mucaji, P.; Grancai, D.; Nagy, M. Antioxidative properties of methanol extracts from leaves and fruits of Ligustrum vulgare L. Acta Facult. Pharm. Univ. Comenianae 2005, 52, 204-209.
8. Jantova, S.; Nagy, M.; Ruzekova, L.; Grancai, D. Cytotoxic activity of plant extracts from the families Fabaceae, Oleaceae, Philadelphaceae, Rosaceae and Staphyleaceae. Phytother. Res. 2001, 15, 22-25.
9. He, Z.D.; Lau, K.M.; But, P.P.; Jiang, R.W.; Dong, H.; Ma, S.C.; Fung, K.P.; Ye, W.C.; Sun, H.D. Antioxidative glycosides from the leaves of Ligustrum robustum. J. Nat. Prod. 2003, 66, 851-854.
10. Cragg, M.G.; Newman, D.J. Plants as a source of anticancer agents. J. Ethopharmacol. 2005, 100, 72-79.
11. Reddy, L.; Odhav, B.; Bhoola, K. Natural products for cancer prevention: global perspective. Pharmacol. Ther. 2003, 99, 1-13.
12. Houghton, P. The role of plants in traditional medicine and current therapy. J. Alt. Comple. Med. 1995, 1, 131-143.
13. Lippert, B. Cisplatin: Chemistry and Biochemistry of a Leading Anticancer Drug; VHCA & WileynVCH: Zurich, Switzerland, 1999.
14. Kosmider, B.; Wyszynska, K.; Janik-Spiechowicz, E.; Osiecka, R.; Zyner, E.; Ochocki, J.; Ciesielska, E.; Wasowicz, W. Evaluation of the genotoxicity of cis-bis(3-aminoflavone) dichloroplatinum(II) in comparison with cis-DDP. Mutat. Res. 2004, 558, 93-110.
15. Stanković, M.; Ćurčić, M; Žižić, J.; Topuzović, M.; Solujić, S.; Marković, S. Teucrium plant species as natural sources of novel anticancer compounds: antiproliferative, proapoptotic and antioxidant properties. Int. J. Mol. Sci. 2011, 12, 4190-4205.
16. Kampa, M.; Nifli, A.P.; Notas, G.; Castanas, E. Polyphenols and cancer cell growth. Rev. Physiol. Biochem. Pharmacol. 2007, 159, 79-113.
17. Galati, G.; Teng, S.; Moridani, M.Y.; Chan, T.S.; O'Brien, P.J. Cancer chemoprevention and apoptosis mechanism induced by diatary polyphenolics. Drug Metabol. Drug Interact. 2000, 17, 311-349.
18. Oh, H.; Livingston, R.; Smith, K.; Abrishamian-Garcia, L. Comparative study of the time dependency of cell death assays. MIT Undergranduate Res. J. 2004, 11, 53-62.
19. Darzynkiewicz, Z.; Traganos, F.; Wu, J.M.; Chen, S. Chinese herbal mixture PC SPES in treatment of prostate cancer (review). Int. J. Oncol. 2000, 17, 729-736.
20. Nagy, M.; Sersen, F. Free radical scavenging activity of different extracts and some constituents from the leaves of Ligustrum vulgare and L. delavayanum. Fitoterapia 2006, 77, 395-397.
21. Von Hoff, D.D.; Layard, M.W.; Basa, P.; Davis, H.L.; Von Hoff, A.L.; Rozencweig, M.; Muggia, F.M. Risk factors for doxorubicininduced congestive heart failure. Ann. Intern. Med. 1979, 91, 710-717.
22. Raghavan, D.; Koczwara, B.; Javle, M. Evolving strategies of cytotoxic chemotherapy for advanced prostate cancer. Eur. J. Cancer 1997, 33, 566-574.
23. Hortobagyi, G.N. Progress in systemic chemotherapy of primary breast cancer: an overview. J. Natl. Cancer Inst. Monogr. 2001, 30, 72-79.
24. Tyagi, A.K.; Singh, R.P.; Agarwal, C.; Chan, D.C.; Agarwal, R. Silibinin strongly synergizes human prostate carcinoma DU145 cells to doxorubicin-induced growth Inhibition, G2-Marrest, and apoptosis. Clin. Cancer Res. 2002, 8, 3512-3519.
25. Cetin, R.; Devrim, E.; Kilicoglu, B.; Avci, A.; Candir, O.; Durak, I. Cisplatin impairs antioxidant system and causes oxidation in rat kidney tissues: Possible protective roles of natural antioxidant foods. J. Appl. Toxicol. 2006, 1, 42-46.
26. Keter, F.K. Pyrazole and pyrazolyl palladium(II) and platinum(II) complexes: synthesis and in vitro evaluation as anticancer agents. M.S. Thesis, University of the Western Cape, Cape Town, South Africa, November 2004.
27. Ferguson, P.; Kurowska, E.; Freman, D.; Chambers, A.; Koropatnick, D. A flavonoid fraction from cranberry extract inhibits proliferation of human tumor cell line. J. Natur. 2004, 134, 1529-1535.
28. Robi, T.; Bishayee, A. Terpenoids and brest cancer chemoprevention. Brest cancer Res. Treat. 2009, 115, 223-239.
29. Zhang, K.; Chew, M.; Wong, K.P. Modulation of cisplatin cytotoxcity and cisplatin-induced DNA crosslink in HepG2 cells by regulation of glutatione-related mechanisms. Mol. Pharmacol. 2001, 59, 837-843.
30. Suzuki, T.; Nishio, K.; Tanabe, S. The MRP family anticancer drug metabolism. Curr. Drug Metab. 2001, 2, 368-377.
31. Journauh, Y.; Sletten, J.; Kahn, O. Tunable interaction in p-Oxamido Copper(II) Binuclear Complexes. Inorg. Chem. 1985, 24, 4063-4069.
32. Mosmann, T. Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J. Immunol. Meth. 1983, 65, 55-63.
33. Baskić, D.; Popović, S.; Ristić, P.; Arsenijević, N.N. Analysis of cyclohexamide-induced apoptosis in human leukocytes: Fluorescence microscopy using annexin V/propidium iodide versus acridin orange/ethidium bromide. Cell Biol. Int. 2006, 30, 924-932.